Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD.
about
Comparison of outcomes after donor lymphocyte infusion with or without prior chemotherapy for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature.Copper-associated hepatitis in a patient with chronic myeloid leukemia following hematopoietic stem cell transplantation: A case report.Treatment of relapsed/refractory acute myeloid leukaemia in adults.
P2860
Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lymphodepleting chemotherapy w ...... but therapy-responsive aGvHD.
@en
Lymphodepleting chemotherapy w ...... but therapy-responsive aGvHD.
@nl
type
label
Lymphodepleting chemotherapy w ...... but therapy-responsive aGvHD.
@en
Lymphodepleting chemotherapy w ...... but therapy-responsive aGvHD.
@nl
prefLabel
Lymphodepleting chemotherapy w ...... but therapy-responsive aGvHD.
@en
Lymphodepleting chemotherapy w ...... but therapy-responsive aGvHD.
@nl
P2093
P2860
P356
P1476
Lymphodepleting chemotherapy w ...... but therapy-responsive aGvHD.
@en
P2093
D Weisdorf
J S Miller
M MacMillan
M R Verneris
P2860
P2888
P304
P356
10.1038/BMT.2016.63
P407
P577
2016-04-11T00:00:00Z
P6179
1008662908